{"id":"https://openalex.org/W7223122018","doi":"https://doi.org/10.1016/j.htct.2026.108392","title":"BLINATUMOMABE EM LEUCEMIA LINFOBL\u00c1STICA AGUDA DE LINHAGEM B PEDI\u00c1TRICA: PERFIL DE TOXICIDADE E DESFECHOS CL\u00cdNICOS EM COORTE DE CENTRO \u00daNICO","display_name":"BLINATUMOMABE EM LEUCEMIA LINFOBL\u00c1STICA AGUDA DE LINHAGEM B PEDI\u00c1TRICA: PERFIL DE TOXICIDADE E DESFECHOS CL\u00cdNICOS EM COORTE DE CENTRO \u00daNICO","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223122018","doi":"https://doi.org/10.1016/j.htct.2026.108392"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.108392","doi":"https://doi.org/10.1016/j.htct.2026.108392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108392","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926021395/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926021395/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093967601","display_name":"Larissa Yasmin da Silva Marques","orcid":"https://orcid.org/0009-0009-5555-8582","observed_orcids":["https://orcid.org/0009-0009-5555-8582"]},"institutions":[{"id":"https://openalex.org/I4210094761","display_name":"Support group for adolescents and children with cancer","ror":"https://ror.org/007492963","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210094761"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Larissa Yasmin da Silva MARQUES","raw_affiliation_strings":["Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210094761","https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159205196","display_name":"Nancy Silva SANTOS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094761","display_name":"Support group for adolescents and children with cancer","ror":"https://ror.org/007492963","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210094761"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Nancy Silva SANTOS","raw_affiliation_strings":["Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210094761","https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159178087","display_name":"Orlei ARAUJO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094761","display_name":"Support group for adolescents and children with cancer","ror":"https://ror.org/007492963","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210094761"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Orlei ARAUJO","raw_affiliation_strings":["Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210094761","https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122583299","display_name":"Dafne Cardoso Bourguignon da Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dafne Cardoso Bourguignon DA SILVA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009337331","display_name":"Elizabete Delbuono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094761","display_name":"Support group for adolescents and children with cancer","ror":"https://ror.org/007492963","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210094761"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Elizabete DELBUONO","raw_affiliation_strings":["Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210094761","https://openalex.org/I88273585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111612666","display_name":"Ana Virginia Lopes de Sousa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094761","display_name":"Support group for adolescents and children with cancer","ror":"https://ror.org/007492963","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210094761"]},{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Virginia Lopes de SOUSA","raw_affiliation_strings":["Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Apoio ao Adolescente e \u00e0 Crian\u00e7a com C\u00e2ncer (GRAACC), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210094761","https://openalex.org/I88273585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.78979489,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"108392","last_page":"108392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.8790000081062317},{"id":"https://openalex.org/keywords/toxicity-profile","display_name":"toxicity profile","score":0.5730000138282776},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9649999737739563},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9750000238418579},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.6019999980926514},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9020000100135803},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.5789999961853027},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5680000185966492},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.6039999723434448},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.3070000112056732},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.3179999887943268},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8112999796867371},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3269999921321869},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3131999969482422},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.23330000042915344},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.16429999470710754},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16410000622272491},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.11429999768733978},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.1096000000834465},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.10750000178813934},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.10450000315904617}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.108392","doi":"https://doi.org/10.1016/j.htct.2026.108392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108392","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926021395/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:9a46c961cfab4148894ed64cbcbadf95","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/9a46c961cfab4148894ed64cbcbadf95","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 108392- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.108392","doi":"https://doi.org/10.1016/j.htct.2026.108392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108392","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926021395/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223122018.pdf","grobid_xml":"https://content.openalex.org/works/W7223122018.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223139130","https://openalex.org/W7223102456","https://openalex.org/W4413287109","https://openalex.org/W4307267984","https://openalex.org/W4403569159","https://openalex.org/W7005777942","https://openalex.org/W4394995747","https://openalex.org/W4306254349","https://openalex.org/W4392867997","https://openalex.org/W2890277045"],"abstract_inverted_index":{"Introdu\u00e7\u00e3o":[0],"O":[1,261,298,402],"blinatumomabe,":[2,382],"anticorpo":[3],"biespec\u00edfico":[4],"anti-CD19/CD3,":[5],"\u00e9":[6,306],"utilizado":[7],"no":[8,347],"tratamento":[9,139,262],"da":[10,282,427,446],"leucemia":[11],"linfobl\u00e1stica":[12],"aguda":[13],"(LLA)":[14],"de":[15,21,36,39,49,51,71,79,84,109,113,121,133,136,146,192,211,219,251,253,284,289,300,322,324,334,342,349,373,391,406,416,423,448,453,459],"linhagem":[16,85],"B":[17,86,103],"pedi\u00e1trica":[18,305],"em":[19,32,88,169,174,177,182,187,194,206,214,226,240,246,257,268,275,328,389,425],"contextos":[20],"recidiva,":[22,354],"doen\u00e7a":[23,123,283,361,372,432,447],"residual":[24,124],"mensur\u00e1vel":[25,125],"positiva":[26,202],"e,":[27],"mais":[28,42,234,318,345,426],"recentemente,":[29],"como":[30,316,386],"consolida\u00e7\u00e3o":[31,173],"primeira":[33,175,220,350,436],"linha.":[34,221,437],"Apesar":[35],"apresentar":[37],"perfil":[38,70,299,405],"toxicidade":[40,72,266,301,379,407],"considerado":[41],"favor\u00e1vel":[43],"que":[44,352],"a":[45,105,153,231,292,314,332,371,378,451],"quimioterapia":[46],"convencional,":[47],"s\u00edndrome":[48,250,321],"libera\u00e7\u00e3o":[50,252,323],"citocinas,":[52],"neurotoxicidade":[53,327],"e":[54,75,92,111,128,131,140,190,213,249,320,326,360,376,421],"febre":[55,232,315],"s\u00e3o":[56],"eventos":[57,419],"adversos":[58,223,420],"reconhecidos,":[59],"com":[60,82,101,156,200,308,313,396,413,431],"potencial":[61],"impacto":[62],"na":[63,311,353,435],"condu\u00e7\u00e3o":[64],"do":[65,73,138,381],"tratamento.":[66,339],"Objetivos":[67],"Descrever":[68],"o":[69,233,309],"blinatumomabe":[74,106,403],"os":[76,198],"desfechos":[77],"cl\u00ednicos":[78],"pacientes":[80,99,171,199,228,242,259,277,395,430],"pedi\u00e1tricos":[81,100],"LLA":[83,102,185],"tratados":[87],"centro":[89],"\u00fanico.":[90],"Material":[91],"M\u00e9todos":[93],"Estudo":[94],"observacional,":[95],"retrospectivo,":[96],"incluindo":[97,244,394],"36":[98],"submetidos":[104],"entre":[107,159],"abril":[108],"2017":[110],"maio":[112],"2026.":[114],"Foram":[115],"analisados":[116],"idade,":[117],"sexo,":[118],"contexto":[119,348],"cl\u00ednico":[120],"indica\u00e7\u00e3o,":[122],"(DRM)":[126],"pr\u00e9":[127],"p\u00f3s-tratamento,":[129],"ocorr\u00eancia":[130],"tipo":[132],"toxicidade,":[134],"necessidade":[135,452],"suspens\u00e3o":[137,417],"desfecho":[141],"cl\u00ednico.":[142],"Resultados":[143],"A":[144,165,340,366,438],"mediana":[145],"idade":[147],"foi":[148,167,255,263,344],"7,5":[149],"anos":[150],"(11":[151],"meses":[152],"19":[154],"anos),":[155],"distribui\u00e7\u00e3o":[157],"semelhante":[158],"sexos":[160],"(18":[161],"meninos,":[162],"18":[163],"meninas).":[164],"indica\u00e7\u00e3o":[166],"recidiva":[168,212],"25":[170],"(69,4%),":[172],"linha":[176,351],"8":[178],"(22,2%),":[179],"falha":[180],"indut\u00f3ria":[181],"1":[183,188,195],"(2,8%),":[184],"secund\u00e1ria":[186],"(2,8%)":[189],"persist\u00eancia":[191],"DRM":[193,201,343,424],"(2,8%).":[196],"Entre":[197],"pr\u00e9-tratamento,":[203],"houve":[204],"negativa\u00e7\u00e3o":[205,341,422],"12/21":[207],"(57,1%)":[208],"dos":[209,217,429],"casos":[210,218,271],"6/8":[215],"(75,0%)":[216],"Eventos":[222],"foram":[224],"documentados":[225],"28/36":[227],"(77,8%),":[229],"sendo":[230],"frequente":[235,346],"(22/36;":[236],"61,1%).":[237],"Neurotoxicidade":[238],"ocorreu":[239,274],"7":[241],"(19,4%),":[243],"convuls\u00f5es":[245],"3":[247],"(8,3%),":[248],"citocinas":[254,325],"documentada":[256],"5":[258],"(13,9%).":[260],"suspenso":[264],"por":[265,280,418],"limitante":[267,337],"apenas":[269],"2":[270],"(5,6%).":[272],"\u00d3bito":[273],"14/36":[276],"(38,9%),":[278],"predominantemente":[279,408],"progress\u00e3o":[281,445],"base":[285,374],"(9/14;":[286],"64,3%),":[287],"seguida":[288],"complica\u00e7\u00f5es":[290],"relacionadas":[291],"TCTH":[293,397],"p\u00f3s-blinatumomabe":[294],"(3/14;":[295],"21,4%).":[296],"Discuss\u00e3o":[297],"observado":[302],"nesta":[303,410],"coorte":[304,411],"consistente":[307],"descrito":[310],"literatura,":[312],"manifesta\u00e7\u00e3o":[317],"comum":[319],"frequ\u00eancia":[329],"relativamente":[330],"baixa,":[331],"maioria":[333],"gravidade":[335],"n\u00e3o":[336,377],"ao":[338],"refletindo":[355],"provavelmente":[356],"menor":[357],"carga":[358],"tumoral":[359],"menos":[362],"quimiorresistente":[363],"nesse":[364],"cen\u00e1rio.":[365],"elevada":[367],"mortalidade":[368,439],"refletiu":[369],"majoritariamente":[370],"refrat\u00e1ria/recidivada,":[375],"direta":[380],"refor\u00e7ando":[383,450],"seu":[384],"papel":[385],"ponte":[387],"terap\u00eautica":[388],"popula\u00e7\u00e3o":[390,458],"alto":[392],"risco,":[393],"pr\u00e9vio":[398],"ou":[399],"subsequente.":[400],"Conclus\u00e3o":[401],"apresentou":[404],"manej\u00e1vel":[409],"pedi\u00e1trica,":[412],"baixa":[414],"taxa":[415],"metade":[428],"mensur\u00e1vel,":[433],"especialmente":[434],"observada":[440],"esteve":[441],"associada":[442],"principalmente":[443],"\u00e0":[444],"base,":[449],"vigil\u00e2ncia":[454],"cl\u00ednica":[455],"cont\u00ednua":[456],"nessa":[457],"risco":[460],"elevado.":[461]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}